'We are talking about a company that is going from strength to strength'
  • 3 months ago
Chief Market Analyst at Scope Markets Joshua Mahony speaks to CGTN Europe about the earnings and performance of the Danish multinational pharmaceutical company Novo Nordisk.
Recommended